Source briefing
DZ Mafia Denies Threatening French Mayor, Arson Attack on Influencer
A French mayor was placed under police protection and a social media influencer's car was torched in a series of violent incidents linked to Marseille's “DZ Mafia.” The group denied any involvement.
Read →
Source briefing
Russia Charges Telegram Founder Durov With Aiding Terrorism
Russia’s FSB accused Pavel Durov of aiding terrorism and placed him on an international wanted list, escalating pressure on Telegram amid restrictions on the messaging service.
Read →
Source briefing
Seroprevalence of Influenza A(H5N1) Virus in Domestic Cats at Epicenter of Dairy Cattle Outbreaks, California, USA, 2024–2026
I. G. Bemis et al.
Read →Source briefing
Human medicines European public assessment report (EPAR): Icotyde, icotrokinra hydrochloride, Status: Opinion
Human medicines European public assessment report (EPAR): Icotyde, icotrokinra hydrochloride, Status: Opinion
Read →Source briefing
Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion
Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion
Read →
Source briefing
Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Date of authorisation: 30/06/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Date of authorisation: 30/06/2026, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 10, Status: Authorised
Read →
Source briefing
Template – Application for transfer of marketing authorisation from transferor to transferee, attachment 1 (veterinary)
Template - Application for transfer of marketing authorisation from transferor to transferee, attachment 1 (veterinary)
Read →Source briefing
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 9, Status: Authorised
Read →